Shionogi sees COVID pill reaping $2 billion in annual sales upon U.S. approval
By Rocky Swift TOKYO (Reuters) – Japan’s Shionogi & Co Ltd believes its COVID-19 pill will easily garner $2 billion in annual sales if it …
shionogi
By Rocky Swift TOKYO (Reuters) – Japan’s Shionogi & Co Ltd believes its COVID-19 pill will easily garner $2 billion in annual sales if it …